T 1282/22 (Vaccination and OX40 agonists/CUREVAC) of 26.08.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T128222.20240826
- Date of decision
- 26 August 2024
- Case number
- T 1282/22
- Petition for review of
- -
- Application number
- 14716752.2
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Combination of vaccination and OX40 agonists
- Applicant name
- CureVac SE
- Opponent name
- BioNTech SE
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.